Aviël Ragamin Anouk E M Nouwen Virgil A S H Dalm Minke M F van Mierlo Carsten R Lincke Suzanne G M A Pasmans
10.1159/000525987
Dermatology
2023;239(1):72-80.
anakinra dupilumab intravenous immunoglobulins ixekizumab netherton syndrome
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/35998563/
Immunoglobulins, Intravenous / therapeutic use Netherton Syndrome / drug therapy
Immunoglobulins, Intravenous / therapeutic use Netherton Syndrome / drug therapy Humans Interleukin 1 Receptor Antagonist Protein / therapeutic use Retrospective Studies Treatment Outcome ixekizumab dupilumab Immunoglobulins, Intravenous Interleukin 1 Receptor Antagonist Protein
PMC9909717
35998563
Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series
2023